Laura Entis

Most Recent Articles by Laura Entis

Five things for pharma marketers to know: Tuesday, February 20, 2018

Five things for pharma marketers to know: Tuesday, February 20, 2018

By

Gilead wins reversal of $2.5 billion payment order; Aimmune Therapeutics' peanut allergy therapy shows promise; AstraZeneca wins FDA approval on key cancer drug.

Five things for pharma marketers to know: Tuesday, February 13, 2018

Five things for pharma marketers to know: Tuesday, February 13, 2018

By

Amazon moves into medical supply market; Big Pharma gets a tax cut; Former Celgene CEO plans Senate run.

Payers: High-deductible health plans don't drive positive consumer behavior

Payers: High-deductible health plans don't drive positive consumer behavior

By

As the evidence mounts that high-deductibles don't cause patients to shop or save for healthcare, payers are taking note.

Five things for pharma marketers to know: Monday, February 12, 2018

Five things for pharma marketers to know: Monday, February 12, 2018

By

White House limits guidance documents; Top executives exit Axovant; Carroll nominated as drug czar.

Five things for pharma marketers to know: Friday, February 9, 2018

Five things for pharma marketers to know: Friday, February 9, 2018

By

Study: Two prostate cancer drugs delay metastasis by two years; Budget deal funds CHIP for four years; Azar outlines Trump's drug pricing plans.

More Articles by Laura Entis